Lodestar Investment Counsel’s Bristol-Myers Squibb BMY Stock Holding History

Lodestar Investment Counsel’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$5.16M	Buy	113,720 +5,579	+5%	+$260K	0.53%	55
2019 Q1	$5.16M	Buy	108,141 +50,048	+86%	+$2.49M	0.55%	54
2018 Q4	$3.02M	Sell	58,093 -52,354	-47%	-$2.81M	0.37%	59
2018 Q3	$6.86M	Sell	110,447 -2,396	-2%	-$142K	0.74%	44
2018 Q2	$6.25M	Sell	112,843 -5,726	-5%	-$309K	0.72%	45
2018 Q1	$7.5M	Sell	118,569 -1,972	-2%	-$127K	0.87%	43
2017 Q4	$7.39M	Sell	120,541 -2,472	-2%	-$155K	0.85%	43
2017 Q3	$7.84M	Sell	123,013 -2,593	-2%	-$151K	0.96%	42
2017 Q2	$7M	Sell	125,606 -12	-0%	-$653	0.89%	45
2017 Q1	$6.83M	Buy	125,618 +29	+0%	+$1.59K	0.89%	45
2016 Q4	$7.34M	Sell	125,589 -23,538	-16%	-$1.29M	0.99%	41
2016 Q3	$8.04M	Buy	149,127 +122,982	+470%	+$7.9M	1.11%	40
2016 Q2	$1.92M	Buy	26,145 +7,860	+43%	+$555K	0.27%	60
2016 Q1	$1.17M	Buy	18,285 +10,985	+150%	+$693K	0.17%	68
2015 Q4	$502K	Sell	7,300 -300	-4%	-$19.8K	0.08%	101
2015 Q3	$450K	Hold	7,600	–	–	0.08%	102
2015 Q2	$506K	Buy	7,600 +75	+1%	+$4.94K	0.08%	101
2015 Q1	$485K	Buy	7,525 +1,575	+26%	+$98.6K	0.07%	103
2014 Q4	$351K	Sell	5,950 -100	-2%	-$5.64K	0.1%	89
2014 Q3	$310K	Hold	6,050	–	–	0.09%	93
2014 Q2	$293K	Sell	6,050 -2,000	-25%	-$98.6K	0.09%	97
2014 Q1	$418K	Sell	8,050 -1,500	-16%	-$79.8K	0.13%	82
2013 Q4	$508K	Sell	9,550 -350	-4%	-$17.8K	0.16%	67
2013 Q3	$458K	Hold	9,900	–	–	0.17%	66
2013 Q2	$442K	Buy	+9,900	New	+$430K	0.17%	65

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Lodestar Investment Counsel's BMY Position: Q2 2019 in Review

Lodestar Investment Counsel increased its Bristol-Myers Squibb (BMY) stake by 5.2% in Q2 2019, buying an estimated $260K and bringing the position to 113,720 shares worth $5.16M. The position accounts for 0.53% of the portfolio, ranked #55.

Lodestar Investment Counsel first reported a position in BMY in Q2 2013 and has held it in 25 quarters since. The position peaked at $8.04M in Q3 2016. 1,777 funds tracked by Wall St. Rank hold BMY as of Q2 2019.

Lodestar Investment Counsel held 113,720 shares of Bristol-Myers Squibb worth $5.16M as of Q2 2019.
Lodestar Investment Counsel bought 5,579 Bristol-Myers Squibb shares in Q2 2019, an estimated $260K.
Bristol-Myers Squibb made up 0.53% of Lodestar Investment Counsel's portfolio in Q2 2019, its #55 holding.
Lodestar Investment Counsel first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 25 quarters since.
Lodestar Investment Counsel's Bristol-Myers Squibb position peaked at $8.04M in Q3 2016.
1,777 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2019.

Based on Lodestar Investment Counsel's 13F filing for Q2 2019, filed 10 Jul 2019.